As regards the developmental efforts to increase muscle quality, bezafibrate, which has been used to treat liver cirrhosis and targets PPARs, is the subject of a phase II clinical trial on T2DM, and chiglitazar sodium, a PPAR pan-agonist, recently approved in China for the treatment of T2DM (Table 1) [171]
While these events were generally mild and rarely led to treatment discontinuation, this represents a unique side effect profile that prospective users should understand before starting treatment
Glutathione is an important antioxidant that scavenges free radicals inside and outside the cell and promotes detoxification
This article is not offering medical advice and should be used for informational purposes only
Its also a time to assess for any potential signs of side effects such as pancreatitis
Iyengar NM, Hudis CA, Dannenberg AJ (2013) Obesity and inflammation: new insights into breast cancer development and progression